Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by MediWound Ltd.

< Previous 1 2 Next >
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
From MediWound Ltd.
Via GlobeNewswire
Tickers ENLV MDWD
MediWound to Report Third Quarter 2023 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD MMM
MediWound Deploys NexoBrid® for Emergency Supply
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces U.S. Commercial Availability of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound’s NexoBrid® Highlighted in 20 Oral and Poster Presentations at the 20th European Burns Association Congress
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound to Participate in Fireside Chat at H.C. Wainwright 25th Annual Global Investment Conference
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Reports Second Quarter 2023 Financial Results and Provides Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces Collaboration with Mölnlycke on EscharEx® Phase III Study
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces Collaboration with MIMEDX on EscharEx® Phase III Study
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD MDXG
MediWound to Report Second Quarter 2023 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces Commercial Launch of NexoBrid® in Japan
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces Positive Results in Its U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell Carcinoma
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Receives Positive Scientific Advice from European Medicine Agency (EMA) on EscharEx Phase III Study Design
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound to Participate in Fireside Chat at Maxim Group Healthcare Virtual Conference 2023
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Reports First Quarter 2023 Financial Results and Provides a Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound to Report First Quarter 2023 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces an Additional $10 Million Award from BARDA
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound to Present Phase 2 EscharEx® Data at the Symposium on Advanced Wound Care (SAWC) Spring 2023
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Reports Fourth Quarter and Full Year 2022 Financial Results and Company Update
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces the Appointment of Hani Luxenburg as Chief Financial Officer
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Expands its Global Leadership Team to Help Drive Company’s Future Growth
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound to Report Fourth Quarter and Year-End 2022 Financial Results
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound to Present Corporate Highlights at Upcoming Investor Conferences
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces Closing of $27.5 Million Registered Direct Offering of Ordinary Shares
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces $27.5 Million Registered Direct Offering of Ordinary Shares Priced At-The-Market
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
MediWound Announces FDA Approval of NexoBrid® for the Treatment of Severe Thermal Burns in Adults
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD VCEL
MediWound Expands NexoBrid’s Global Presence with Marketing Approval in Japan
From MediWound Ltd.
Via GlobeNewswire
Tickers MDWD
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS